402MO Final results of the CARACAS study: Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment.
Saved in:
| Title: | 402MO Final results of the CARACAS study: Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment. |
|---|---|
| Authors: | Lonardi, S.1 (AUTHOR), Pietrantonio, F.2 (AUTHOR), Prete, A.A.1 (AUTHOR), Messina, M.3 (AUTHOR), Formica, V.4 (AUTHOR), Corsi, D.C.5 (AUTHOR), Cortesi, E.6 (AUTHOR), Frassineti, L.G.7 (AUTHOR), Zampino, M.G.8 (AUTHOR), Ronzoni, M.9 (AUTHOR), Scartozzi, M.10 (AUTHOR), Casagrande, M.11 (AUTHOR), Conca, V.12 (AUTHOR), Bergamo, F.1 (AUTHOR), Prisciandaro, M.2 (AUTHOR), Intini, R.1 (AUTHOR), Antista, M.2 (AUTHOR), Paola, D.B.13 (AUTHOR), Vettore, V.1 (AUTHOR), Zagonel, V.1 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS412-S412. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152695093 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 402MO Final results of the CARACAS study: Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lonardi%2C+S%2E%22">Lonardi, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pietrantonio%2C+F%2E%22">Pietrantonio, F.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Prete%2C+A%2EA%2E%22">Prete, A.A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Messina%2C+M%2E%22">Messina, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Formica%2C+V%2E%22">Formica, V.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Corsi%2C+D%2EC%2E%22">Corsi, D.C.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cortesi%2C+E%2E%22">Cortesi, E.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Frassineti%2C+L%2EG%2E%22">Frassineti, L.G.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zampino%2C+M%2EG%2E%22">Zampino, M.G.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ronzoni%2C+M%2E%22">Ronzoni, M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scartozzi%2C+M%2E%22">Scartozzi, M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Casagrande%2C+M%2E%22">Casagrande, M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Conca%2C+V%2E%22">Conca, V.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bergamo%2C+F%2E%22">Bergamo, F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Prisciandaro%2C+M%2E%22">Prisciandaro, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Intini%2C+R%2E%22">Intini, R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Antista%2C+M%2E%22">Antista, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Paola%2C+D%2EB%2E%22">Paola, D.B.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vettore%2C+V%2E%22">Vettore, V.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zagonel%2C+V%2E%22">Zagonel, V.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS412-S412. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152695093 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.513 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S412 Titles: – TitleFull: 402MO Final results of the CARACAS study: Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lonardi, S. – PersonEntity: Name: NameFull: Pietrantonio, F. – PersonEntity: Name: NameFull: Prete, A.A. – PersonEntity: Name: NameFull: Messina, M. – PersonEntity: Name: NameFull: Formica, V. – PersonEntity: Name: NameFull: Corsi, D.C. – PersonEntity: Name: NameFull: Cortesi, E. – PersonEntity: Name: NameFull: Frassineti, L.G. – PersonEntity: Name: NameFull: Zampino, M.G. – PersonEntity: Name: NameFull: Ronzoni, M. – PersonEntity: Name: NameFull: Scartozzi, M. – PersonEntity: Name: NameFull: Casagrande, M. – PersonEntity: Name: NameFull: Conca, V. – PersonEntity: Name: NameFull: Bergamo, F. – PersonEntity: Name: NameFull: Prisciandaro, M. – PersonEntity: Name: NameFull: Intini, R. – PersonEntity: Name: NameFull: Antista, M. – PersonEntity: Name: NameFull: Paola, D.B. – PersonEntity: Name: NameFull: Vettore, V. – PersonEntity: Name: NameFull: Zagonel, V. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2020 Supplement 4 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
